Janine Kimpel

2.5k total citations · 1 hit paper
68 papers, 1.5k citations indexed

About

Janine Kimpel is a scholar working on Infectious Diseases, Genetics and Animal Science and Zoology. According to data from OpenAlex, Janine Kimpel has authored 68 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Infectious Diseases, 24 papers in Genetics and 14 papers in Animal Science and Zoology. Recurrent topics in Janine Kimpel's work include SARS-CoV-2 and COVID-19 Research (32 papers), Virus-based gene therapy research (24 papers) and COVID-19 Clinical Research Studies (21 papers). Janine Kimpel is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (32 papers), Virus-based gene therapy research (24 papers) and COVID-19 Clinical Research Studies (21 papers). Janine Kimpel collaborates with scholars based in Austria, Germany and United States. Janine Kimpel's co-authors include Dorotheé von Laer, Annika Rössler, Guido Wollmann, Wegene Borena, Lydia Riepler, Herbert Tilg, Andreas Zollner, Zoltán Bánki, Reinhard Tober and Alexander Muik and has published in prestigious journals such as Nature Communications, The Journal of Immunology and Gastroenterology.

In The Last Decade

Janine Kimpel

65 papers receiving 1.5k citations

Hit Papers

Postacute COVID-19 is Characterized by Gut Viral Antigen ... 2022 2026 2023 2024 2022 50 100 150

Peers

Janine Kimpel
Sven D. Koch Germany
Ruth Watkinson United Kingdom
Natalie J. Thornburg United States
Adeline Chia Singapore
Guy R. Simpson United Kingdom
Janine Kimpel
Citations per year, relative to Janine Kimpel Janine Kimpel (= 1×) peers Alexander Muik

Countries citing papers authored by Janine Kimpel

Since Specialization
Citations

This map shows the geographic impact of Janine Kimpel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janine Kimpel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janine Kimpel more than expected).

Fields of papers citing papers by Janine Kimpel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janine Kimpel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janine Kimpel. The network helps show where Janine Kimpel may publish in the future.

Co-authorship network of co-authors of Janine Kimpel

This figure shows the co-authorship network connecting the top 25 collaborators of Janine Kimpel. A scholar is included among the top collaborators of Janine Kimpel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janine Kimpel. Janine Kimpel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zollner, Andreas, Robert Koch, Almina Jukic, et al.. (2024). Clearance of Gut Mucosal SARS-CoV-2 Antigens and Postacute COVID-19 After 2 Years in Patients With Inflammatory Bowel Disease. Gastroenterology. 167(3). 604–607.e8. 3 indexed citations
2.
Rössler, Annika, Antonia Netzl, Ludwig Knabl, et al.. (2024). Direct comparison of SARS-CoV-2 variant specific neutralizing antibodies in human and hamster sera. npj Vaccines. 9(1). 85–85. 3 indexed citations
3.
Zollner, Andreas, Annika Rössler, Janine Kimpel, et al.. (2023). B and T Cell Responses to SARS-CoV-2 Vaccination in Kidney and Liver Transplant Recipients with and without Previous COVID-19. Viruses. 16(1). 1–1.
4.
Riepler, Lydia, et al.. (2023). No evidence for epitranscriptomic m5C modification of SARS-CoV-2, HIV and MLV viral RNA. RNA. 29(6). 756–763. 9 indexed citations
5.
Falkensammer, Barbara, David Bante, Maria Huber, et al.. (2023). Retained avidity despite reduced cross-binding and cross-neutralizing antibody levels to Omicron after SARS-COV-2 wild-type infection or mRNA double vaccination. Frontiers in Immunology. 14. 1196988–1196988. 1 indexed citations
6.
Perdiguero, Beatriz, Carmen Gómez, David Peterhoff, et al.. (2023). Potency and durability of T and B cell immune responses after homologous and heterologous vector delivery of a trimer-stabilized, membrane-displayed HIV-1 clade ConC Env protein. Frontiers in Immunology. 14. 1270908–1270908. 1 indexed citations
7.
Fischhuber, Katrin, Zoltán Bánki, Janine Kimpel, et al.. (2023). Antiviral Potential of Azelastine against Major Respiratory Viruses. Viruses. 15(12). 2300–2300. 2 indexed citations
8.
Zollner, Andreas, Robert Koch, Almina Jukic, et al.. (2022). Postacute COVID-19 is Characterized by Gut Viral Antigen Persistence in Inflammatory Bowel Diseases. Gastroenterology. 163(2). 495–506.e8. 173 indexed citations breakdown →
9.
Rössler, Annika, Janine Kimpel, Silke Huber, et al.. (2022). Regimen of Coronavirus Disease 2019 Vaccination Influences Extent and Kinetics of Antibody Avidity. The Journal of Infectious Diseases. 226(11). 1909–1912. 1 indexed citations
10.
Kimpel, Janine, et al.. (2022). Impacts of rapid mass vaccination against SARS-CoV2 in an early variant of concern hotspot. Nature Communications. 13(1). 612–612. 15 indexed citations
11.
Heilmann, Emmanuel, Janine Kimpel, Benedikt Hofer, et al.. (2021). Chemogenetic ON and OFF switches for RNA virus replication. Nature Communications. 12(1). 1362–1362. 7 indexed citations
12.
Belnoue, Elodie, Matteo A. C. Rossi, Tamara Hofer, et al.. (2021). A modular self-adjuvanting cancer vaccine combined with an oncolytic vaccine induces potent antitumor immunity. Nature Communications. 12(1). 5195–5195. 41 indexed citations
13.
Baumgartner, Matthias R., Janine Kimpel, Annika Rössler, et al.. (2021). Marked Increase in Avidity of SARS-CoV-2 Antibodies 7–8 Months After Infection Is Not Diminished in Old Age. The Journal of Infectious Diseases. 224(5). 764–770. 25 indexed citations
14.
Zollner, Andreas, Annika Rössler, Maria R. Farcet, et al.. (2021). B and T cell response to SARS-CoV-2 vaccination in health care professionals with and without previous COVID-19. EBioMedicine. 70. 103539–103539. 54 indexed citations
15.
Borena, Wegene, Zoltán Bánki, Katie Bates, et al.. (2021). Persistence of immunity to SARS-CoV-2 over time in the ski resort Ischgl. EBioMedicine. 70. 103534–103534. 12 indexed citations
16.
Knabl, Ludwig, Tanmay Mitra, Janine Kimpel, et al.. (2021). High SARS-CoV-2 seroprevalence in children and adults in the Austrian ski resort of Ischgl. Communications Medicine. 1(1). 4–4. 38 indexed citations
17.
Deisenhammer, Florian, Dagmar Rudzki, Annika Rössler, et al.. (2021). 12-month SARS-CoV-2 antibody persistency in a Tyrolean COVID-19 cohort. Wiener klinische Wochenschrift. 133(23-24). 1265–1271. 2 indexed citations
18.
Kimpel, Janine, Fabian Heinemann, Birgit Stierstorfer, et al.. (2019). The lytic activity of VSV-GP treatment dominates the therapeutic effects in a syngeneic model of lung cancer. British Journal of Cancer. 121(8). 647–658. 32 indexed citations
20.
Muik, Alexander, Lawton J. Stubbert, Janine Kimpel, et al.. (2014). Re-engineering Vesicular Stomatitis Virus to Abrogate Neurotoxicity, Circumvent Humoral Immunity, and Enhance Oncolytic Potency. Cancer Research. 74(13). 3567–3578. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026